Associate Director, Global Programs



Dr. Anthony Carpenter joined Partners Harvard Medical International in 2008. He works with PHMI team members and faculty on international programs focused on quality improvement and patient safety. He brings to these collaborations an extensive background in the delivery of clinical care in Internal Medicine. 

Prior to joining PHMI, Dr. Carpenter served in a number of clinical positions in Internal Medicine and Anatomical Pathology in leading tertiary hospital centers in Australia, including the Royal Melbourne Hospital, the Monash Medical Centre, and the Canberra Hospital.

Dr. Carpenter has extensive teaching experience at the undergraduate and postgraduate level. He was also an Instructor in Medicine at Mannix College at the University of Melbourne, and Mannix College at Monash University. He has extensive experience lecturing in Anatomy and Physiology, and was a facilitator in the University of New South Wales’ Faculty of Medicine Program for Indigenous Medical Students. 

Prior to entering medicine, Dr. Carpenter was employed as a Financial Risk Management Consultant with a leading global financial services firm. In this role he conducted research on emerging financial and credit market issues, and applied financial modeling to assist corporations in managing financial and credit risk.

Dr. Carpenter’s interests include the economic rationale and efficiency of health care system design and delivery, and how the financial structure of health care systems impacts upon access, equity, and health outcomes. He is also interested in postgraduate medical training and retention strategies in the acute care setting.

Dr. Carpenter is an Honors Graduate of two of Australia’s most prestigious Universities. He graduated with a Bachelor of Commerce, and completed his Honors year in Applied Finance, at the University of Melbourne.  His honor’s thesis at the University of Melbourne used non-linear optimization techniques to examine the ability of traded share price data to predict the risk of corporate collapse. He also has significant training in Applied Finance, Economics, and Econometrics. He received his medical degree from the University of New South Wales, where he was awarded prizes for his research into a novel class of nucleic acids, and recognized for excellence in pediatric medicine. He is undertaking further study at the Harvard School of Public Health in the areas of health care financing, economics, and health system policy and reform.